Page last updated: 2024-12-05

ferrocin c

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

N-methyl-2-quinolone: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID11820
CHEMBL ID216146
SCHEMBL ID248619
MeSH IDM0213520

Synonyms (47)

Synonym
ai3-24119
unii-uq470vv48x
uq470vv48x ,
nsc 5873
1-methyl-2-quinolinone
1-methyl-1,2-dihydroquinolin-2-one
mls002637847 ,
n-methylcarbostyril
1-methylcarbostyril
2(1h)-quinolinone, 1-methyl-
nsc-5873
1-methyl-2-quinolone
nsc5873
606-43-9
carbostyril, 1-methyl-
1-methyl-2(1h)-quinolone
1-methyl-2(1h)-quinolinone
1-methylquinolin-2(1h)-one
c3b n-methyl-2-quinolone
1-methylquinolin-2-one
AO-840/40233519
qyemnjmsulgqrd-uhfffaoysa-
inchi=1/c10h9no/c1-11-9-5-3-2-4-8(9)6-7-10(11)12/h2-7h,1h3
DB04580
AKOS000276919
smr001547359
CHEMBL216146 ,
STK736383
A832822
147172-12-1
FT-0632523
F3308-4039
SCHEMBL248619
n-methyl-2-quinolone
1-methyl-quinolin-2-one
DTXSID1060552
n-methyl-quinolin-2-one
HMS3604D09
mfcd00024051
bdbm50157646
CS-W023164
HR-0330
Q27095322
1-methyl-1h-quinolin-2-one
2-hydroxy-1-methylquinoline
PD005991
SY130700
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (9)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Carbonic anhydrase 12Homo sapiens (human)Ki0.08350.00021.10439.9000AID1387634
Bromodomain-containing protein 4Homo sapiens (human)IC50 (µMol)73.00000.00040.40329.0500AID1483636
Carbonic anhydrase 1Homo sapiens (human)Ki10.00000.00001.372610.0000AID1387631
Carbonic anhydrase 2Homo sapiens (human)Ki10.00000.00000.72369.9200AID1387632
PeregrinHomo sapiens (human)IC50 (µMol)4.80004.80004.80004.8000AID1483626
Carbonic anhydrase 9Homo sapiens (human)Ki0.04460.00010.78749.9000AID1387633
Histone acetyltransferase KAT2BHomo sapiens (human)IC50 (µMol)70.00005.00006.01678.5000AID1483695
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Bromodomain-containing protein 9Homo sapiens (human)Kd5.00005.00006.50008.0000AID1289198
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (68)

Processvia Protein(s)Taxonomy
estrous cycleCarbonic anhydrase 12Homo sapiens (human)
chloride ion homeostasisCarbonic anhydrase 12Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 12Homo sapiens (human)
regulation of transcription by RNA polymerase IIBromodomain-containing protein 4Homo sapiens (human)
positive regulation of G2/M transition of mitotic cell cycleBromodomain-containing protein 4Homo sapiens (human)
positive regulation of transcription elongation by RNA polymerase IIBromodomain-containing protein 4Homo sapiens (human)
chromatin organizationBromodomain-containing protein 4Homo sapiens (human)
DNA damage responseBromodomain-containing protein 4Homo sapiens (human)
positive regulation of transcription elongation by RNA polymerase IIBromodomain-containing protein 4Homo sapiens (human)
positive regulation of canonical NF-kappaB signal transductionBromodomain-containing protein 4Homo sapiens (human)
positive regulation of DNA-templated transcriptionBromodomain-containing protein 4Homo sapiens (human)
positive regulation of transcription by RNA polymerase IIBromodomain-containing protein 4Homo sapiens (human)
regulation of inflammatory responseBromodomain-containing protein 4Homo sapiens (human)
positive regulation of T-helper 17 cell lineage commitmentBromodomain-containing protein 4Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 1Homo sapiens (human)
morphogenesis of an epitheliumCarbonic anhydrase 2Homo sapiens (human)
positive regulation of synaptic transmission, GABAergicCarbonic anhydrase 2Homo sapiens (human)
positive regulation of cellular pH reductionCarbonic anhydrase 2Homo sapiens (human)
angiotensin-activated signaling pathwayCarbonic anhydrase 2Homo sapiens (human)
regulation of monoatomic anion transportCarbonic anhydrase 2Homo sapiens (human)
secretionCarbonic anhydrase 2Homo sapiens (human)
regulation of intracellular pHCarbonic anhydrase 2Homo sapiens (human)
neuron cellular homeostasisCarbonic anhydrase 2Homo sapiens (human)
positive regulation of dipeptide transmembrane transportCarbonic anhydrase 2Homo sapiens (human)
regulation of chloride transportCarbonic anhydrase 2Homo sapiens (human)
carbon dioxide transportCarbonic anhydrase 2Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 2Homo sapiens (human)
chromatin remodelingPeregrinHomo sapiens (human)
regulation of DNA-templated transcriptionPeregrinHomo sapiens (human)
positive regulation of DNA-templated transcriptionPeregrinHomo sapiens (human)
regulation of developmental processPeregrinHomo sapiens (human)
regulation of hemopoiesisPeregrinHomo sapiens (human)
regulation of transcription by RNA polymerase IIPeregrinHomo sapiens (human)
response to hypoxiaCarbonic anhydrase 9Homo sapiens (human)
morphogenesis of an epitheliumCarbonic anhydrase 9Homo sapiens (human)
response to xenobiotic stimulusCarbonic anhydrase 9Homo sapiens (human)
response to testosteroneCarbonic anhydrase 9Homo sapiens (human)
secretionCarbonic anhydrase 9Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 9Homo sapiens (human)
positive regulation of DNA-templated transcriptionATPase family AAA domain-containing protein 2Homo sapiens (human)
transcription initiation-coupled chromatin remodelingATPase family AAA domain-containing protein 2Homo sapiens (human)
nucleosome disassemblyATPase family AAA domain-containing protein 2Homo sapiens (human)
nucleosome assemblyATPase family AAA domain-containing protein 2Homo sapiens (human)
negative regulation of transcription by RNA polymerase IIHistone acetyltransferase KAT2BHomo sapiens (human)
positive regulation of transcription from RNA polymerase II promoter by glucoseHistone acetyltransferase KAT2BHomo sapiens (human)
gluconeogenesisHistone acetyltransferase KAT2BHomo sapiens (human)
regulation of DNA repairHistone acetyltransferase KAT2BHomo sapiens (human)
chromatin remodelingHistone acetyltransferase KAT2BHomo sapiens (human)
regulation of DNA-templated transcriptionHistone acetyltransferase KAT2BHomo sapiens (human)
regulation of transcription by RNA polymerase IIHistone acetyltransferase KAT2BHomo sapiens (human)
protein acetylationHistone acetyltransferase KAT2BHomo sapiens (human)
heart developmentHistone acetyltransferase KAT2BHomo sapiens (human)
memoryHistone acetyltransferase KAT2BHomo sapiens (human)
negative regulation of cell population proliferationHistone acetyltransferase KAT2BHomo sapiens (human)
regulation of protein ADP-ribosylationHistone acetyltransferase KAT2BHomo sapiens (human)
positive regulation of neuron projection developmentHistone acetyltransferase KAT2BHomo sapiens (human)
N-terminal peptidyl-lysine acetylationHistone acetyltransferase KAT2BHomo sapiens (human)
internal peptidyl-lysine acetylationHistone acetyltransferase KAT2BHomo sapiens (human)
peptidyl-lysine acetylationHistone acetyltransferase KAT2BHomo sapiens (human)
cellular response to insulin stimulusHistone acetyltransferase KAT2BHomo sapiens (human)
cellular response to oxidative stressHistone acetyltransferase KAT2BHomo sapiens (human)
vasodilationHistone acetyltransferase KAT2BHomo sapiens (human)
regulation of RNA splicingHistone acetyltransferase KAT2BHomo sapiens (human)
positive regulation of gluconeogenesisHistone acetyltransferase KAT2BHomo sapiens (human)
positive regulation of fatty acid biosynthetic processHistone acetyltransferase KAT2BHomo sapiens (human)
transcription initiation-coupled chromatin remodelingHistone acetyltransferase KAT2BHomo sapiens (human)
positive regulation of glycolytic processHistone acetyltransferase KAT2BHomo sapiens (human)
positive regulation of DNA-templated transcriptionHistone acetyltransferase KAT2BHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIHistone acetyltransferase KAT2BHomo sapiens (human)
regulation of embryonic developmentHistone acetyltransferase KAT2BHomo sapiens (human)
negative regulation of centriole replicationHistone acetyltransferase KAT2BHomo sapiens (human)
rhythmic processHistone acetyltransferase KAT2BHomo sapiens (human)
regulation of cell divisionHistone acetyltransferase KAT2BHomo sapiens (human)
regulation of cell cycleHistone acetyltransferase KAT2BHomo sapiens (human)
limb developmentHistone acetyltransferase KAT2BHomo sapiens (human)
cellular response to parathyroid hormone stimulusHistone acetyltransferase KAT2BHomo sapiens (human)
regulation of tubulin deacetylationHistone acetyltransferase KAT2BHomo sapiens (human)
positive regulation of attachment of mitotic spindle microtubules to kinetochoreHistone acetyltransferase KAT2BHomo sapiens (human)
negative regulation of rRNA processingHistone acetyltransferase KAT2BHomo sapiens (human)
chromatin remodelingBromodomain-containing protein 9Homo sapiens (human)
regulation of transcription by RNA polymerase IIBromodomain-containing protein 9Homo sapiens (human)
biological_processBromodomain-containing protein 9Homo sapiens (human)
positive regulation of cell population proliferationBromodomain-containing protein 9Homo sapiens (human)
negative regulation of cell differentiationBromodomain-containing protein 9Homo sapiens (human)
positive regulation of stem cell population maintenanceBromodomain-containing protein 9Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (41)

Processvia Protein(s)Taxonomy
zinc ion bindingCarbonic anhydrase 12Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 12Homo sapiens (human)
transcription cis-regulatory region bindingBromodomain-containing protein 4Homo sapiens (human)
p53 bindingBromodomain-containing protein 4Homo sapiens (human)
chromatin bindingBromodomain-containing protein 4Homo sapiens (human)
transcription coregulator activityBromodomain-containing protein 4Homo sapiens (human)
transcription coactivator activityBromodomain-containing protein 4Homo sapiens (human)
protein bindingBromodomain-containing protein 4Homo sapiens (human)
RNA polymerase II CTD heptapeptide repeat kinase activityBromodomain-containing protein 4Homo sapiens (human)
enzyme bindingBromodomain-containing protein 4Homo sapiens (human)
lysine-acetylated histone bindingBromodomain-containing protein 4Homo sapiens (human)
RNA polymerase II C-terminal domain bindingBromodomain-containing protein 4Homo sapiens (human)
P-TEFb complex bindingBromodomain-containing protein 4Homo sapiens (human)
histone reader activityBromodomain-containing protein 4Homo sapiens (human)
arylesterase activityCarbonic anhydrase 1Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 1Homo sapiens (human)
protein bindingCarbonic anhydrase 1Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 1Homo sapiens (human)
hydro-lyase activityCarbonic anhydrase 1Homo sapiens (human)
cyanamide hydratase activityCarbonic anhydrase 1Homo sapiens (human)
arylesterase activityCarbonic anhydrase 2Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 2Homo sapiens (human)
protein bindingCarbonic anhydrase 2Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 2Homo sapiens (human)
cyanamide hydratase activityCarbonic anhydrase 2Homo sapiens (human)
histone H4K5 acetyltransferase activityPeregrinHomo sapiens (human)
histone H4K8 acetyltransferase activityPeregrinHomo sapiens (human)
histone H4K12 acetyltransferase activityPeregrinHomo sapiens (human)
DNA bindingPeregrinHomo sapiens (human)
protein bindingPeregrinHomo sapiens (human)
acetyltransferase activator activityPeregrinHomo sapiens (human)
metal ion bindingPeregrinHomo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 9Homo sapiens (human)
protein bindingCarbonic anhydrase 9Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 9Homo sapiens (human)
molecular function activator activityCarbonic anhydrase 9Homo sapiens (human)
protein bindingATPase family AAA domain-containing protein 2Homo sapiens (human)
ATP bindingATPase family AAA domain-containing protein 2Homo sapiens (human)
ATP hydrolysis activityATPase family AAA domain-containing protein 2Homo sapiens (human)
histone bindingATPase family AAA domain-containing protein 2Homo sapiens (human)
chromatin bindingATPase family AAA domain-containing protein 2Homo sapiens (human)
RNA polymerase II transcription regulatory region sequence-specific DNA bindingHistone acetyltransferase KAT2BHomo sapiens (human)
chromatin bindingHistone acetyltransferase KAT2BHomo sapiens (human)
transcription coregulator activityHistone acetyltransferase KAT2BHomo sapiens (human)
transcription coactivator activityHistone acetyltransferase KAT2BHomo sapiens (human)
diamine N-acetyltransferase activityHistone acetyltransferase KAT2BHomo sapiens (human)
histone acetyltransferase activityHistone acetyltransferase KAT2BHomo sapiens (human)
lysine N-acetyltransferase activity, acting on acetyl phosphate as donorHistone acetyltransferase KAT2BHomo sapiens (human)
cyclin-dependent protein serine/threonine kinase inhibitor activityHistone acetyltransferase KAT2BHomo sapiens (human)
protein bindingHistone acetyltransferase KAT2BHomo sapiens (human)
acetyltransferase activityHistone acetyltransferase KAT2BHomo sapiens (human)
protein kinase bindingHistone acetyltransferase KAT2BHomo sapiens (human)
histone acetyltransferase bindingHistone acetyltransferase KAT2BHomo sapiens (human)
histone deacetylase bindingHistone acetyltransferase KAT2BHomo sapiens (human)
histone H3K9 acetyltransferase activityHistone acetyltransferase KAT2BHomo sapiens (human)
peptide-lysine-N-acetyltransferase activityHistone acetyltransferase KAT2BHomo sapiens (human)
DNA-binding transcription factor bindingHistone acetyltransferase KAT2BHomo sapiens (human)
histone H3 acetyltransferase activityHistone acetyltransferase KAT2BHomo sapiens (human)
nucleic acid bindingBromodomain-containing protein 9Homo sapiens (human)
protein bindingBromodomain-containing protein 9Homo sapiens (human)
lysine-acetylated histone bindingBromodomain-containing protein 9Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (28)

Processvia Protein(s)Taxonomy
plasma membraneCarbonic anhydrase 12Homo sapiens (human)
membraneCarbonic anhydrase 12Homo sapiens (human)
basolateral plasma membraneCarbonic anhydrase 12Homo sapiens (human)
apical plasma membraneCarbonic anhydrase 12Homo sapiens (human)
plasma membraneCarbonic anhydrase 12Homo sapiens (human)
condensed nuclear chromosomeBromodomain-containing protein 4Homo sapiens (human)
nucleusBromodomain-containing protein 4Homo sapiens (human)
nucleoplasmBromodomain-containing protein 4Homo sapiens (human)
cytosolCarbonic anhydrase 1Homo sapiens (human)
extracellular exosomeCarbonic anhydrase 1Homo sapiens (human)
cytoplasmCarbonic anhydrase 2Homo sapiens (human)
cytosolCarbonic anhydrase 2Homo sapiens (human)
plasma membraneCarbonic anhydrase 2Homo sapiens (human)
myelin sheathCarbonic anhydrase 2Homo sapiens (human)
apical part of cellCarbonic anhydrase 2Homo sapiens (human)
extracellular exosomeCarbonic anhydrase 2Homo sapiens (human)
cytoplasmCarbonic anhydrase 2Homo sapiens (human)
plasma membraneCarbonic anhydrase 2Homo sapiens (human)
apical part of cellCarbonic anhydrase 2Homo sapiens (human)
nucleusPeregrinHomo sapiens (human)
nucleoplasmPeregrinHomo sapiens (human)
cytoplasmPeregrinHomo sapiens (human)
cytosolPeregrinHomo sapiens (human)
plasma membranePeregrinHomo sapiens (human)
MOZ/MORF histone acetyltransferase complexPeregrinHomo sapiens (human)
histone acetyltransferase complexPeregrinHomo sapiens (human)
nucleolusCarbonic anhydrase 9Homo sapiens (human)
plasma membraneCarbonic anhydrase 9Homo sapiens (human)
membraneCarbonic anhydrase 9Homo sapiens (human)
basolateral plasma membraneCarbonic anhydrase 9Homo sapiens (human)
microvillus membraneCarbonic anhydrase 9Homo sapiens (human)
plasma membraneCarbonic anhydrase 9Homo sapiens (human)
nucleusATPase family AAA domain-containing protein 2Homo sapiens (human)
nucleoplasmATPase family AAA domain-containing protein 2Homo sapiens (human)
extracellular exosomeATPase family AAA domain-containing protein 2Homo sapiens (human)
nucleusATPase family AAA domain-containing protein 2Homo sapiens (human)
SAGA complexHistone acetyltransferase KAT2BHomo sapiens (human)
kinetochoreHistone acetyltransferase KAT2BHomo sapiens (human)
nucleusHistone acetyltransferase KAT2BHomo sapiens (human)
nucleoplasmHistone acetyltransferase KAT2BHomo sapiens (human)
centrosomeHistone acetyltransferase KAT2BHomo sapiens (human)
cytosolHistone acetyltransferase KAT2BHomo sapiens (human)
A bandHistone acetyltransferase KAT2BHomo sapiens (human)
I bandHistone acetyltransferase KAT2BHomo sapiens (human)
actomyosinHistone acetyltransferase KAT2BHomo sapiens (human)
mitotic spindleHistone acetyltransferase KAT2BHomo sapiens (human)
ATAC complexHistone acetyltransferase KAT2BHomo sapiens (human)
protein-containing complexHistone acetyltransferase KAT2BHomo sapiens (human)
chromatinBromodomain-containing protein 9Homo sapiens (human)
nucleusBromodomain-containing protein 9Homo sapiens (human)
nucleoplasmBromodomain-containing protein 9Homo sapiens (human)
GBAF complexBromodomain-containing protein 9Homo sapiens (human)
SWI/SNF complexBromodomain-containing protein 9Homo sapiens (human)
nucleusBromodomain-containing protein 9Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (29)

Assay IDTitleYearJournalArticle
AID1387631Inhibition of recombinant human carbonic anhydrase 1 incubated 15 mins prior to testing by CO2 hydration based stopped-flow assay2018ACS medicinal chemistry letters, Sep-13, Volume: 9, Issue:9
Heterocoumarins Are Selective Carbonic Anhydrase IX and XII Inhibitors with Cytotoxic Effects against Cancer Cells Lines.
AID1445036Inhibition of recombinant human NNMT triple mutant expressed in Escherichia coli BL21/DE3 cells using NCA as substrate assessed as decrease in 1-MN formation in presence of SAM, SAH by HPLC-UV method2017Journal of medicinal chemistry, 06-22, Volume: 60, Issue:12
Structure-Activity Relationship for Small Molecule Inhibitors of Nicotinamide N-Methyltransferase.
AID343398Octanol-water distribution coefficient, log D at pH 7.4 by shake-flask technique2008Journal of medicinal chemistry, Jul-10, Volume: 51, Issue:13
Toward prediction of alkane/water partition coefficients.
AID1387634Inhibition of recombinant human carbonic anhydrase 12 incubated 15 mins prior to testing by CO2 hydration based stopped-flow assay2018ACS medicinal chemistry letters, Sep-13, Volume: 9, Issue:9
Heterocoumarins Are Selective Carbonic Anhydrase IX and XII Inhibitors with Cytotoxic Effects against Cancer Cells Lines.
AID1483695Inhibition of human PCAF expressed in Escherichia coli BL21 after 1 hr by BROMOscan assay2017Journal of medicinal chemistry, 01-26, Volume: 60, Issue:2
Design of a Biased Potent Small Molecule Inhibitor of the Bromodomain and PHD Finger-Containing (BRPF) Proteins Suitable for Cellular and in Vivo Studies.
AID1360419Cytotoxicity against human HepG2 cells assessed as decrease in cell viability after 72 hrs by MTT assay2018European journal of medicinal chemistry, Jul-15, Volume: 155Novel 8-nitroquinolin-2(1H)-ones as NTR-bioactivated antikinetoplastid molecules: Synthesis, electrochemical and SAR study.
AID1483637Inhibition of human ATAD2A expressed in Escherichia coli BL21 after 1 hr by BROMOscan assay2017Journal of medicinal chemistry, 01-26, Volume: 60, Issue:2
Design of a Biased Potent Small Molecule Inhibitor of the Bromodomain and PHD Finger-Containing (BRPF) Proteins Suitable for Cellular and in Vivo Studies.
AID1483636Inhibition of human BRD4-BD1 expressed in Escherichia coli BL21 after 1 hr by BROMOscan assay2017Journal of medicinal chemistry, 01-26, Volume: 60, Issue:2
Design of a Biased Potent Small Molecule Inhibitor of the Bromodomain and PHD Finger-Containing (BRPF) Proteins Suitable for Cellular and in Vivo Studies.
AID1360417Antileishmanial activity against axenic amastigote stage of Leishmania infantum MHOM/MA/67/ITMAP-263 assessed as inhibition of parasite metabolic activity after 48 hrs by luciferase reporter assay2018European journal of medicinal chemistry, Jul-15, Volume: 155Novel 8-nitroquinolin-2(1H)-ones as NTR-bioactivated antikinetoplastid molecules: Synthesis, electrochemical and SAR study.
AID1483626Inhibition of human BRPF1 expressed in Escherichia coli BL21 after 1 hr by BROMOscan assay2017Journal of medicinal chemistry, 01-26, Volume: 60, Issue:2
Design of a Biased Potent Small Molecule Inhibitor of the Bromodomain and PHD Finger-Containing (BRPF) Proteins Suitable for Cellular and in Vivo Studies.
AID1483627Inhibition of human BRD9 expressed in Escherichia coli BL21 after 1 hr by BROMOscan assay2017Journal of medicinal chemistry, 01-26, Volume: 60, Issue:2
Design of a Biased Potent Small Molecule Inhibitor of the Bromodomain and PHD Finger-Containing (BRPF) Proteins Suitable for Cellular and in Vivo Studies.
AID1282488Binding affinity to recombinant N-terminal His-tagged PCAF (715 to 831 residues) (unknown origin) expressed in Escherichia coli Rosetta cells at 1 mM by differential scanning fluorimetry2016Journal of medicinal chemistry, Feb-25, Volume: 59, Issue:4
Structure-Based Identification of Inhibitory Fragments Targeting the p300/CBP-Associated Factor Bromodomain.
AID1360418Antitrypanosomal activity against trypomastigote stage of Trypanosoma brucei brucei AnTat 1.9 assessed as decrease in parasite viability after 69 hrs by Alamar Blue assay2018European journal of medicinal chemistry, Jul-15, Volume: 155Novel 8-nitroquinolin-2(1H)-ones as NTR-bioactivated antikinetoplastid molecules: Synthesis, electrochemical and SAR study.
AID1289198Binding affinity to BRD9 (unknown origin) by isothermal titration calorimetric analysis2016Journal of medicinal chemistry, Feb-25, Volume: 59, Issue:4
Disrupting Acetyl-Lysine Recognition: Progress in the Development of Bromodomain Inhibitors.
AID1483709Binding affinity to human PCAF assessed as change in melting temperature at 1 mM by real-time PCR method2017Journal of medicinal chemistry, 01-26, Volume: 60, Issue:2
Design of a Biased Potent Small Molecule Inhibitor of the Bromodomain and PHD Finger-Containing (BRPF) Proteins Suitable for Cellular and in Vivo Studies.
AID1387632Inhibition of recombinant human carbonic anhydrase 2 incubated 15 mins prior to testing by CO2 hydration based stopped-flow assay2018ACS medicinal chemistry letters, Sep-13, Volume: 9, Issue:9
Heterocoumarins Are Selective Carbonic Anhydrase IX and XII Inhibitors with Cytotoxic Effects against Cancer Cells Lines.
AID343680Hexadecane-water distribution coefficient, log D at pH 7.4 by shake-flask technique2008Journal of medicinal chemistry, Jul-10, Volume: 51, Issue:13
Toward prediction of alkane/water partition coefficients.
AID1387633Inhibition of recombinant human carbonic anhydrase 9 incubated 15 mins prior to testing by CO2 hydration based stopped-flow assay2018ACS medicinal chemistry letters, Sep-13, Volume: 9, Issue:9
Heterocoumarins Are Selective Carbonic Anhydrase IX and XII Inhibitors with Cytotoxic Effects against Cancer Cells Lines.
AID273433Inhibition of Trypanosoma brucei brucei growth2006Journal of medicinal chemistry, Oct-05, Volume: 49, Issue:20
Using fragment cocktail crystallography to assist inhibitor design of Trypanosoma brucei nucleoside 2-deoxyribosyltransferase.
AID1872632Antibacterial activity against Mycobacterium tuberculosis measured after 14 days2022European journal of medicinal chemistry, Mar-15, Volume: 232Quinoline heterocyclic containing plant and marine candidates against drug-resistant Mycobacterium tuberculosis: A systematic drug-ability investigation.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (12)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (25.00)29.6817
2010's8 (66.67)24.3611
2020's1 (8.33)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.97

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.97 (24.57)
Research Supply Index2.64 (2.92)
Research Growth Index4.61 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.97)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other13 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]